To confirm the roles of CD44 and TNFSF14 as potential targets, functional studies—such as co-culture experiments of GBM cells with immune cells, gene knockout models, and advanced techniques like single-cell sequencing—are required. The gene discussed is TNFSF14; the disease is glioblastoma.